<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 9)
Food Technology Service, Inc.
(formerly Vindicator, Inc.)
------------------------------------------------------------------------------
(Name of Issuer)
Common Shares, $0.01 Par Value
------------------------------------------------------------------------------
(Title of Class of Securities)
927341107
------------------------------------------------------------------------------
(CUSIP Number)
David L. Nicholds, Esq.
MDS Nordion Inc.
447 March Road
Kanata, Ontario, Canada K2K 1X8
------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
NOVEMBER 20, 2000
------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement
If the filing person has previously filed a statement on Schedule 13D to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]
Check the following box if a fee is being paid with the statement [ ]. (A fee
is not required only if the reporting person: (1) has a pervious statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
<PAGE> 2
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purposes of Section 13 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 3
SCHEDULE 13D
CUSIP NO. 927341107 PAGE 1 OF 5 PAGES
--------------------- -------- --------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON.
MDS Nordion Inc. (formerly Nordion International Inc.)
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC & Affiliate
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e).
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION.
Ontario, Canada
---------------------------------------------------------------------
(7) SOLE VOTING POWER:
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER: 6,189,306
OWNED BY
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER:
PERSON WITH
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER: 6,189,306
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
6,189,306
---------------------------------------------------------------------
(12) CHECK BOX IF AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 55.80%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON* CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 4
SCHEDULE 13D
CUSIP NO. 927341107 PAGE 2 OF 5 PAGES
--------------------- -------- --------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON.
Laboratoires MDS Quebec Ltee
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
Affiliate
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e).
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION.
Quebec, Canada
---------------------------------------------------------------------
(7) SOLE VOTING POWER:
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER: 6,189,306
OWNED BY
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER:
PERSON WITH
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER: 6,189,306
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
6,189,306
---------------------------------------------------------------------
(12) CHECK BOX IF AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 55.80%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON* CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 5
SCHEDULE 13D
CUSIP NO. 927341107 PAGE 3 OF 5 PAGES
--------------------- -------- --------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION OF ABOVE PERSON.
MDS Inc.
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*. (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3) SEC USE ONLY
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC & Affiliate
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ]
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e).
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION.
Ontario, Canada
---------------------------------------------------------------------
(7) SOLE VOTING POWER:
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER: 6,189,306
OWNED BY
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER:
PERSON WITH
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER: 6,189,306
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
6,189,306
---------------------------------------------------------------------
(12) CHECK BOX IF AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 55.80%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON* CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 6
Item 1. SECURITY AND ISSUER.
Shares of Common Stock, $0.01 par value
Food Technology Service, Inc.
502 Prairie Mine Road
Mulberry, Florida 33860 USA
Item 2. IDENTITY AND BACKGROUND
N/A
Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
N/A
Item 4. PURPOSE OF TRANSACTION
Item 4 is hereby amended.
As confirmed by letter Agreement dated May 18, 2000
(previously filed) Food Technology Service, Inc.'s ("FTSI")
indebtedness to MDS Nordion Inc. ("Nordion") as at February
4, 2000 is in the amount of $963,194 (the "Debt"). The Debt
is convertible into shares at the conversion rate of 70% of
the closing price, on the last trade date, prior to the
exercise of the conversion right. Additionally, such Letter
Agreement provides that the right of conversion of interest
on the Debt accruing from February 5, 2000 to January 1,
2001, into shares of FTSI, has been waived by Nordion. The
drop in FTSI's share price has given rise to an increase in
the number of shares, to which Nordion would be beneficially
entitled if it exercised its right of conversion of the Debt.
Since the 13D Amendment 8, filed with the SEC in September
2000, (which computed the amount of beneficially owned shares
based on the closing share price on September 13, 2000 i.e.,
70% of $2.812 or $1.968) the closing share price of FTSI on
November 20, 2000 decreased to $1.875. Seventy percent (70%)
thereof corresponds to a conversion price of $1.3125.
At the close of business on November 20, 2000, Nordion
beneficially owned 6,189,306 shares of stock, which
constitutes approximately 55.80 % of the outstanding shares
of FTSI. The number of shares beneficially owned as of
November 20, 2000 has been computed by aggregating (i) the
number of shares that Nordion actually owns; and (ii) the
number of shares into which Nordion could elect to convert
the remaining outstanding Debt on the basis of the closing
price of November 20, 2000 (i.e., 70% of $1.875 or $1.3125).
As a result of the transaction, the number of shares
beneficially owned by Nordion increased by 244,434 shares.
Pursuant to publicly available information 10,356,576 shares
of Food Technology Service, Inc. were issued and outstanding
on November 20, 2000.
Item 5. INTEREST IN SECURITIES OF THE ISSUER
See Item 4.
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDING OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
By Letter Agreement (attached), MDS Nordion has extended its
waiver of the right of conversion of interest accruing on
outstanding FTSI indebtedness for the period January 1, 2001
to January 1, 2002,into shares of FTSI.
<PAGE> 7
Item 7. MATERIALS TO BE FILED AS EXHIBITS
Letter Agreement.
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief
the undersigned certify that the information set forth in this statement is
true and correct.
Dated: November 27, 2000
MDS NORDION INC.,
By: /s/ David L. Nicholds
-----------------------------------------------
Name: David L. Nicholds
Title: Vice President, General Counsel
MDS INC.,
By: /s/ Peter E. Brent
-----------------------------------------------
Name: Peter E. Brent
Title: Senior Vice President & General Counsel
LABORATOIRES MDS QUEBEC LTEE.
By: /s/ Peter E. Brent
-----------------------------------------------
Name: Peter E. Brent
Title: Vice President & Corporate Secretary
